Cows: For all indications: 3.0 - 5.0ml/animal, corresponding to 0.21 - 0.35mg carbetocin/animal.

Sows: For uterine atony, MMA and milk ejection 1.5 - 3.0ml/animal, corresponding to 0.105 - 0.21mg carbetocin/animal.

For shortening of total parturition duration as a part of the synchronisation of parturition in: 1.0ml/animal, corresponding to 0.07mg carbetocin/animal.

The dosage requirements can be variable within the indicated limits based on the assessment of the veterinarian.

For single intramuscular or intravenous injection. In case of treatment for milk ejection in the cow and sow or supportive therapy in MMA-syndrome in the sow, a repeated administration is possible after 1 to 2 days.

The responsiveness to carbetocin of the myometrium is likely to be close to zero from the 5th to the 11th day post partum. Therefore, the administration of Reprocine during this period is likely to be inefficient and should be avoided.

If treatment with carbetocin should fail, then it is advisable to reconsider the aetiology of the condition, specifically if hypocalcaemia could be a complicating factor.

In case of severe septic metritis, appropriate concomitant therapy should be instigated when administering Reprocine.